PFIZER LIMITED

Improve access to innovative medicines for Irish patients and expedite the reimbursement of Pfizer's new treatment through highlighting delays in the reimbursement process. mBC is an advanced form of breast cancer where early detection does not unfortunately improve survival.…

Highlight delays in the reimbursement process, inquire about status of reimbursement of Pfizer's medicine for metatastic breast cancer, which was approved in the EU by the EMA in November 2016, through question to Minister for Health and build understanding that patients with…

Improve access to innovative medicines for Irish patients by highlighting the current delays at every stage in the process

Highlight delays in the reimbursement process, inquire about status of reimbursement of Pfizer's medicine for metatastic breast cancer, which was approved in the EU by the EMA in November 2016, through question to Minister for Health and build understanding that patients with…

Highlight concerns about delays in the reimbursement process and inquire about status of medicines currently in the reimbursement process through question to Minister for Health.

Highlight potential patient safety concerns about FF private member bill designed to amend the Health Act 2013 to allow biologic medicines be deemed interchangeable, which if so designated by the regulator, would mean that a pharmacist could provide a biosimilar version of the…

Build understanding of the significance of the savings being provided, the mechanisms involved and how this creates significant headroom to reimburse new medicines ensuring Irish patients have timely access to innovative medicines

Build understanding that patients with metastatic breast cancer need new treatments and Pfizer will start seeking reimbursement for Ibrance in Ireland and is hopeful that timely reimbursement will be secured so that patients can get access to this first new therapy in over 10…

raise political and public awareness of metastatic breast cancer where scientific progress has not kept pace with early breast cancer and where patients have distinct needs, require better services, and need to feel that their story is recognised in the public discourse about…

To ensure an Agreement was reached. An Agreement was reached providing extensive savings to pharmaceutical expenditure through price cuts bringing the price of on-patent medicines in Ireland in line with 14 other European countries and providing greater detail on the process…

To highlight the impact of health cuts during austerity and emphasise the importance of investment in health - the research results showed public concern about health cuts and showed that the public place health investment as a priority.